The purpose of this study is to evaluate the efficacy of high-intensity non invasive mechanical ventilation (during one year to reduce the severity and frequency of acute exacerbation of chronic obstructive pulmonary disease (AECOPD) in patients with frequent AECOPD (frequent exacerbations defined more two or more AECOPD) and in GOLD IV stage (very severe COPD). The design is a randomised, double blind and controled with placebo (sham maneuver) clinical trial.
Background: * There are many previous studies (no controlled trials or observational studies)that demonstrated minimal benefits (on gas exchange and marginal effect over exacerbations frequency) with the use of non invasive mechanical ventilation, in BiPAP modality with IPAP pressures \<18H2ocm (low intensity), in COPD patients. * In subsequent years there were controled trials that concluded that there was no benefits with the use of non invasive mechanical ventilation on BiPAP mode in COPD patients ( It should be mentioned that in most trials were used low inspiratory pressure levels, that is called low-intensity non invasive mechanical ventilation). * However, there are other recent studies that described some benefits of high intensity Bilevel modality of non invasive mechanical ventilation (inspiratory pressures \>18cmH2O) specially on gas exchange, quality of life and functional status. * There are some issues that do not yet have a clear answer like the optimal inspiratory pressure (IPAP) or the ventilation modality (BIPAP or other) to obtain the maximal benefit on COPD patients. Additionally, is not clear also if the use of non invasive mechanical ventilation on COPD patients helps to reduce the frequency and severity of acute exacerbations of COPD (AECOPD). This study have some characteristics that are different to the previous reports: * The inclusion of patients with frequent exacerbations phenotype (and therefore worst prognosis patients)that there are no included in previous trials * The intervention maneuver that is bilevel modality of non invasive mechanical ventilation at hig-intensity pressure (\>18H2Ocm and \<24H2Ocm) * The use of placebo maneuver (CPAP "Sham") * The home titration in three phases, over a week * The long-term use of the intervention and sham maneuver
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
mechanical ventilation type bilevel at high intensity (\>18mmHg) for at least six hours, nocturnal ventilation.
CPAP sham maneuver (IPAP less or equal to 4cmH2O)
National Institute of Respiratory Diseases
Mexico City, Mexico City, Mexico
acute exacerbations of Chronic Obstructive Pulmonary Disease frequency
It will be calculated the exacerbation/year-patien rate and will be compared between groups
Time frame: 1 year
acute exacerbation of chronic obstructive pulmonary disease severity
It will be measured the rate of AECOPD with hospitalary and Intensive Care Unity requirement
Time frame: 1 year
lymphocyte subpopulations Th-1 and Th-17
It will be measured the lymphocyte subpopulations like Th-1 and Th-17
Time frame: 1 year
six-minute walking test
Time frame: 1 year
Forced expiratory volume in first second (FEV1) and forced expiratory capacity
Time frame: 1 year
Maximal inspiratory pressure and maximal expiratory pressure
Time frame: 1 año
gas exchange response (carbon and oxygen dioxide arterial pressure)
Time frame: 1 year
Health related quality of life
Time frame: one year
anxiety and depression measures (HAD and Beck Questionnaires)
Time frame: one year
echocardiographic parameters
Time frame: one year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
SUPPORTIVE_CARE
Masking
DOUBLE
Enrollment
20
survival
Time frame: one year
IL-1 and IL-6 cytokines
it will be measured the level of interleukines 1 and 6(IL-1 and IL-6)
Time frame: one year